Effects of mineralocorticoid receptor antagonists on new-onset or recurrent atrial fibrillation: a Bayesian and frequentist network meta-analysis of randomized trials.

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Paschalis Karakasis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

5 More presentations in this session

Presentation thumbnail

Adherence to the ABC pathway improves prognosis in patients with AF: preliminary findings from an updated meta-analysis of 360,000 patients

Doctor G. Romiti (Rome, IT)

Abstract Slides Video

Presentation thumbnail

Outcome and life expectancy associated with novel subgroups of atrial fibrillation: a data-driven cluster analysis

Doctor Y. Yu (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

Impact of blood pressure control on the risk of stroke and mortality in patients with atrial fibrillation across different ages: a nationwide population-based study

Doctor M. Jeong (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Body mass index may alter cardiovascular outcomes in patients with newly-diagnosed atrial fibrillation and previous stroke: an interaction analysis using longitudinal data from the GLORIA-AF registry

Doctor S. Lam (Liverpool, GB)

Abstract Slides Video

Presentation thumbnail

Diabetes mellitus and adverse clinical events in patients with atrial fibrillation: implications of insulin treatment: a report from the GLORIA-AF Registry Phase III

Doctor B. Huang (Chongqing, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Integrated management of atrial fibrillation: addressing comorbidities, risk factors, and lifestyle

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources